# UNIGENE LABORATORIES INC: Form D filings

UNIGENE LABORATORIES INC, a biotechnology company in Boonton, NJ, filed 3 Form D notices with the SEC between 2010 and 2013. The latest, on April 22, 2013, reports $750,000 sold of a $750,000 offering to 1 investor.

Find out what UNIGENE LABORATORIES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20UNIGENE%20LABORATORIES%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=UNIGENE%20LABORATORIES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Funigene-laboratories-inc-352747)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20UNIGENE%20LABORATORIES%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=UNIGENE%20LABORATORIES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Funigene-laboratories-inc-352747)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 81 FULTON STREET, Boonton, NJ, 07005
- Phone: (973) 265-1100
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 352747

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 22, 2013 | New notice | $750,000 | $750,000 | $0 | 1 | Apr 8, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/352747/000157493913000001/0001574939-13-000001-index.htm) |
| Oct 9, 2012 | New notice | $7,500,000 | $4,000,000 | $3,500,000 | 4 | Sep 21, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/352747/000155956712000001/0001559567-12-000001-index.htm) |
| Mar 29, 2010 | New notice | $36,000,000 | $33,000,000 | $3,000,000 | 1 | Mar 17, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/352747/000035274710000003/0000352747-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Nozer M. Mehta | Executive Officer |  |
| Brian M. Zietsman | Executive Officer |  |
| Roxanne P. Tavakkol | Executive Officer |  |
| Richard Levy | Director |  |
| Paul P. Shields | Executive Officer |  |
| Jack M. Wyszomierski | Director |  |
| Theron M. Odlaug | Director |  |
| Thomas M. Sabatino, Jr. | Director |  |
| Joel M. Tune | Director |  |
| Ashleigh M. Palmer | Executive Officer, Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Apr 22, 2013](https://specstream.ai/data/form-d/week/2013-04-22) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what UNIGENE LABORATORIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).